3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
2
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Precancerous Conditions
1
Neoplasms, Second Primary
1
Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Fibrosis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Adenomatous Polyps
1
Interventions
Fluorouracil
72
Leucovorin
71
Oxaliplatin
47
Irinotecan
31
Capecitabine
24
Bevacizumab
23
Folfox protocol
20
Cetuximab
15
Chemotherapy, Adjuvant
13
Celecoxib
7
Aspirin
6
Laparoscopy
5
XELOX
4
Panitumumab
4
Neoadjuvant Therapy
4
Levamisole
4
dehydroftorafur
3
Tegafur
3
Surgical Procedures, Operative
3
Observation
3
Floxuridine
3
vatalanib
2
tislelizumab
2
pertuzumab
2
encorafenib
2
atezolizumab
2
Trastuzumab
2
Standard of Care
2
Semaxinib
2
Selenium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Colonic Neoplasms
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts